Applications Published 4 October 2000

Published: 26-Apr-2001

The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).


The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).

  • Transdermal therapeutic device and method with capsaicin and capsaicin analogues
    The Regents of the University of California 1039802*

  • Fungicide mixtures based on amide compounds and pyridine derivatives
    BASF 1039803*

  • Method for treating fibrinoproliferative disroders by inhibitors of protease hydroxylation
    Cornell Research Foundation 1039804*

  • Compns for the controlled release of active compounds
    ATO 1039881*

  • Therapeutic formulation for administering tolterodine with controlled release
    Pharmacia & Upjohn 1039882*

  • Method for the treatment of apolipoprotein E related diseases
    Crutcher, Keith 1039883*

  • A method for the prevention and treatment of stunned myocardium
    Orion Corp 1039884*

  • Use of C18 to C26 aliphatic alcohols for the manufacture of a medicament in the treatment of hyperproliferative skin disorders
    Lifak Pharmaceuticals 1039885*

  • Method for the treatment of neuro- and nephro-disorders and therapeutic toxicites using aminothiol compounds
    US Bioscience 1039887*

  • Method of increasing the production and improving the quality of semen
    Astacarotene 1039888*

  • Novel salts of metformin and method
    Bristol-Myers Squibb 1039890*

  • Treatment of scar tissue using lipoic acid
    Perriocone, Nicholas 1039891*

  • Use of polyunsaturated fatty acids for reducing the incidence of necrotising enterocolitis
    Abbott Laboratories; The University of Texas Research Corp 1039892*

  • Pharmaceutical compsns containing an omega-3 fatty acid
    Severson, Mary; Cyclosporine Therapeutics 1039893*

  • Compsns and methods for increasing the concentration and/or motility of spermatozoa in humans
    Sigma-Tau Healthscience 1039894*

  • Use of 3-benzoyl-phenylacetic acids, esters, or amides for the treatment of GLC1A glaucoma
    Alcon Laboratories 1039895*

  • Method and compsn for delivering zinc to the nasal membrane
    Hensley, Charles; Davidson, Robert Steven 1039896*

  • Inadone and tetralone compounds for inhibiting cell proliferation
    The Regents of the University of California 1039897*

  • Pharmaceutical compsn for antagonising CCR5 comprising anilide derivative
    Takeda Chemical Industry 1039899*

  • Pharmaceutical compsn containing sibutramine and orlistat
    Knoll 1039900*

  • Treatment for Alzheimer's disease
    Eli Lilly 1039901*

  • Inhibitors of gap junction communication
    The Scripps Research Institute 1039902*

  • Synergistic antimicrobial compsns
    Goodman, Thomas 1039904*

  • Pharmaceutical formulation comprising glycine as a stabiliser
    Eisai 1039905*

  • Novel metal complexes
    SmithKline Beecham 1039906*

  • Thrombin inhibitor
    Merck 1039907*

  • Molecular dispersion compsn with enhanced bioavailability
    Schering Corp 1039908*

  • Method and compsn of an oral preparation of itraconazole
    Choongwee Pharma Corp 1039909*

  • Use of quinazoline derivatives as tyrosine kinase inhibitors for treating colonic polyps
    American Cyanamid 1039910*

  • Morphplino-N-ethyl ester prodrugs of indole SPLA 2 inhibitors
    Eli Lilly 1039911*

  • Angiostatic agents and compsns for controlling ocular hypertension
    Alcon Laboratories 1039912*

  • Progesterone tablet and preparation method
    Laboratoires BESINS ISCOVESCO 1039913*

  • Cyclooxygenase-2 inhibition
    Cornell Research Foundation 1039914*

  • Cyclic phosphonate ester inhibitors of microsomal triglyceride transfer protein and method
    Brsitol-Myers Squibb 1039915*

  • Use of fucane for regulating the reconstruction of connective tissues
    Institut Francais de Recherche pour l'Exploitation de la Mer (IFREMER) 1039916*

  • Pharmaceutical compsn comprising ticlopidine and ginkgo biloba extract
    Yuyu Industrial Co 1039917*

  • Compsn for improving mental capabilities in mammals
    Pandita, Maharaj Krishen; Dubey, Govind Prashad 1039919*

  • Fatty acid-acylated insulin analogues
    Eli Lilly 1039920*

  • Substantially pure histidine-linked protein conjugate
    Enzon 1039921*

  • Improved interferon polymer conjugates
    Schering 1039922*

  • Gamma-conopeptides
    The University of Utah Research Foundation 1039923*

  • Process using the growth factor IGF-1 in the manufacture of compositions that are useful in the treatment of cerebellar ataxia
    Applied Research Systems 1039924*

  • Alteration of the cell cycle in vivo, and particularly for inducing apoptosis of tumour cells
    Alfacell Corp 1039925*

  • Venezuelan equine encephalitis virus vectors expressing tunour-associated atnigens to induce cancer immunity
    GD Searle 1039926*

  • Intranasal yellow fever vaccination
    Deutsches Primatenzentrum Gesellschaft 1039928*

  • Activated T-cells and their uses
    Yeda Research and Development 1039929*

  • Adjuvated vaccine formulation
    SmithKline Beecham 1039939*

  • Multivalent recombinant antibodies for treating HRV infections
    CFY Biomedicals 1039931*

  • Methods and compsns for the delivery of pharmaceutical agentsand/or the prevention of adhesions
    Alliance Pharmaceutical 1039932*

  • Methods and compsns for enhancing immune response and for the production of (in vitro) MABS
    Cytimmune Sciences 1039933*

  • Substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitors
    Biocryst Pharmaceuticals 1040094*

  • Cyclohexene carboxylates as neuraminidase inhibitors
    Gilead Sciences 1040095*

  • Neuroprotective agents
    The University of Southampton 1040096*

  • Potassium channel openers
    Abbott Laboratories 1040097*

  • Integrin receptor antagonists
    Merck 1040098*

  • Azepine or larger medium ring derivations and their use as pharmaceuticals
    Amgen 1040099*

  • Therapeutically active compounds based on indazole bioisostere replacement of catechol in PDE4 inhibitors
    Pfizer Products 1040100*

  • Substituted 2-aryl-4-amino-chinazoline, method for the production and use thereof as medicaments
    Aventis Pharma Deutschland 1040101*

  • Arylthiazolidinedione derivatives
    Merck 1040102*

  • Ortho-anthranilamide derivatives as anti-coagulants
    Schering 1040108*

  • N-phenylamide and N-pyridinylamide derivatives, method of preparing them and pharmaceutical compsns containing them
    Merck 1040109*

  • Integrin receptor antagonists
    Merck 1040110*

  • Imidazonaphthyridines and their use in inducing cytokine biosynthesis
    Minnesota Mining & Manufacturing 1040112*

  • A scalable method for the isolation of anti-HIV agents from the tropical plant Calophyllum
    Sarawak Medichem Pharmaceuticals 10401113*

  • Method of producing di-organo alkaline earth compounds
    BASF 1040114*

  • Method for the preparation of trinuclear molybdenum-sulphur compounds and their use as lubricant additives
    Infineum USA 1040115*

  • 110 secreted human proteins
    Human Genome Sciences 1040117*

  • Secreted proteins and polynucleotides encoding them
    Genetics Institute 1040118*

  • Hemisterlin analogues
    University of British Columbia 1040119*

  • Antifungal and antibacterial peptides
    Priodontix; Trustees of Boston University 1040120*

  • Novel method for producing cyclosporin derivatives
    Aventis Pharma 1040121*

  • Protein binding polypeptides
    Anmat Technology Limited 1040122*

  • Human papillomavirus vaccine
    SmithKline Beecham Biologicals 1040123*

  • Method of maintaining or restoring tissue-appropriate phenotype of soft tissue cells
    Creative Biomolecules 1040126*
    See more

    • You may also like

    Medical Devices

    Syensqo introduces medical-grade Amodel PPA for single-use, high-temperature medical devices

    Read more
    A new medical-grade Amodel PPA delivers high heat resistance, electrically insulative properties, and biocompatibility for advanced single-use medical instruments and assemblies

    Trending Articles

    1. Continuous innovation: redefining the future of pharmaceutical manufacturing In an industry in which reliability is paramount and change can be slow, GEA has consistently proven that innovation and stability go hand in hand. Almost two decades ago, GEA introduced the first ConsiGma® continuous manufacturing (CM) system to the pharmaceutical market — a pioneering move that helped to reshape how oral solid dosage (OSD) forms are developed and produced
    2. Abselion launches AAVX and AAV9 Total Capsid Quantification Kits Ready-to-use solution for Amperia benchtop platform supports rapid, reliable quantification across a range of serotypes
    3. diaago and Peak Analysis & Automation partner to bring practical automation solutions to research laboratories Using diaago's customer-first approach with PAA’s decades of expertise in laboratory robotics, the collaboration promises to deliver solutions to streamline workflows, boost throughput and reduce bottlenecks
    4. Suncombe and Kindeva collaborate to deliver low-carbon inhalers to the NHS The partnership will develop next-generation pressurised metered-dose inhalers with low Global Warming Potential propellants, helping the NHS move closer to its Net Zero target
    5. Douglas Pharmaceuticals sets new benchmark for capsule quality with CI Precision Partnership delivers compliance confidence, efficiency gains and reduced waste

    Upcoming event

    Enhancing probiotic stability through smarter formulation and packaging strategies

    18 September 2025 | Virtual     See all

    You may also like

    Medical Devices

    Syensqo introduces medical-grade Amodel PPA for single-use, high-temperature medical devices

    A new medical-grade Amodel PPA delivers high heat resistance, electrically insulative properties, and biocompatibility for advanced single-use medical instruments and assemblies
    Manufacturing

    Sapio Sciences introduces world’s first 3rd-generation ELN

    Sapio ELaiN is an AI-powered lab notebook designed to act as a scientific collaborator
    Manufacturing

    Signal Group launches MCERTS approved VOC emissions monitor

    New SOLAR CEMNEX analyser offers advanced compliance and connectivity features
    Research & Development

    Genoskin raises $8.7m in its first funding round to advance its ethical, human-based alternatives to animal testing

    The financing will drive Genoskin’s next phase of growth, with a view to scaling up operations in both the US and France
    You need to be a subscriber to read this article.
    Click here to find out more.
    Packaging

    Cloud labelling and serialisation: the new frontline of traceability in drug delivery

    As drug delivery evolves to accommodate a new wave of data-driven innovation, the need for traceability and compliance throughout the supply chain is paramount. Innovative cloud-based solutions enable pharmaceutical companies to navigate these demands with confidence
    Manufacturing

    Sharp boosts autoinjector and pen assembly line capability with $20m investment in Pennsylvania facility

    The money will boost its autoinjector and pen assembly, labelling and packaging lines across various therapeutic areas at its facility in Macungie, meeting the rising demand for injectables
    Manufacturing

    L.B. Bohle to showcase machines for OSD, food and nutraceuticals at PACK EXPO 2025

    Company to present advanced blending, particle sizing and coating technologies at Las Vegas event
    Subscribe now